Global Xerostomia Therapeutics Supply, Demand and Key Producers, 2023-2029

September 2023 | 112 pages | ID: G8BEB3D21F76EN
GlobalInfoResearch

Abstracts

The global Xerostomia Therapeutics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Xerostomia Therapeutics production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Xerostomia Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Xerostomia Therapeutics that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Xerostomia Therapeutics total production and demand, 2018-2029, (K Units)

Global Xerostomia Therapeutics total production value, 2018-2029, (USD Million)

Global Xerostomia Therapeutics production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Xerostomia Therapeutics consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Xerostomia Therapeutics domestic production, consumption, key domestic manufacturers and share

Global Xerostomia Therapeutics production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Xerostomia Therapeutics production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Xerostomia Therapeutics production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Xerostomia Therapeutics market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline plc, Church & Dwight Co., Inc., Colgate-Palmolive Company, Hikma Pharmaceuticals PLC, Pendopharm, Sun Pharmaceuticals Industries Ltd., Lupin Pharmaceuticals, Inc., Pfizer, Inc. and Parnell Pharmaceuticals, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Xerostomia Therapeutics market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Xerostomia Therapeutics Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Xerostomia Therapeutics Market, Segmentation by Type

• OTC
• Prescription

Global Xerostomia Therapeutics Market, Segmentation by Application

• Hospital
• Clinic
• Other

Companies Profiled:

• GlaxoSmithKline plc
• Church & Dwight Co., Inc.
• Colgate-Palmolive Company
• Hikma Pharmaceuticals PLC
• Pendopharm
• Sun Pharmaceuticals Industries Ltd.
• Lupin Pharmaceuticals, Inc.
• Pfizer, Inc.
• Parnell Pharmaceuticals, Inc.
• Acacia Pharma
• OraCoat

Key Questions Answered

1. How big is the global Xerostomia Therapeutics market?

2. What is the demand of the global Xerostomia Therapeutics market?

3. What is the year over year growth of the global Xerostomia Therapeutics market?

4. What is the production and production value of the global Xerostomia Therapeutics market?

5. Who are the key producers in the global Xerostomia Therapeutics market?

Contents

1 SUPPLY SUMMARY

1.1 Xerostomia Therapeutics Introduction
1.2 World Xerostomia Therapeutics Supply & Forecast
  1.2.1 World Xerostomia Therapeutics Production Value (2018 & 2022 & 2029)
  1.2.2 World Xerostomia Therapeutics Production (2018-2029)
  1.2.3 World Xerostomia Therapeutics Pricing Trends (2018-2029)
1.3 World Xerostomia Therapeutics Production by Region (Based on Production Site)
  1.3.1 World Xerostomia Therapeutics Production Value by Region (2018-2029)
  1.3.2 World Xerostomia Therapeutics Production by Region (2018-2029)
  1.3.3 World Xerostomia Therapeutics Average Price by Region (2018-2029)
  1.3.4 North America Xerostomia Therapeutics Production (2018-2029)
  1.3.5 Europe Xerostomia Therapeutics Production (2018-2029)
  1.3.6 China Xerostomia Therapeutics Production (2018-2029)
  1.3.7 Japan Xerostomia Therapeutics Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Xerostomia Therapeutics Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Xerostomia Therapeutics Major Market Trends

2 DEMAND SUMMARY

2.1 World Xerostomia Therapeutics Demand (2018-2029)
2.2 World Xerostomia Therapeutics Consumption by Region
  2.2.1 World Xerostomia Therapeutics Consumption by Region (2018-2023)
  2.2.2 World Xerostomia Therapeutics Consumption Forecast by Region (2024-2029)
2.3 United States Xerostomia Therapeutics Consumption (2018-2029)
2.4 China Xerostomia Therapeutics Consumption (2018-2029)
2.5 Europe Xerostomia Therapeutics Consumption (2018-2029)
2.6 Japan Xerostomia Therapeutics Consumption (2018-2029)
2.7 South Korea Xerostomia Therapeutics Consumption (2018-2029)
2.8 ASEAN Xerostomia Therapeutics Consumption (2018-2029)
2.9 India Xerostomia Therapeutics Consumption (2018-2029)

3 WORLD XEROSTOMIA THERAPEUTICS MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Xerostomia Therapeutics Production Value by Manufacturer (2018-2023)
3.2 World Xerostomia Therapeutics Production by Manufacturer (2018-2023)
3.3 World Xerostomia Therapeutics Average Price by Manufacturer (2018-2023)
3.4 Xerostomia Therapeutics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Xerostomia Therapeutics Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Xerostomia Therapeutics in 2022
  3.5.3 Global Concentration Ratios (CR8) for Xerostomia Therapeutics in 2022
3.6 Xerostomia Therapeutics Market: Overall Company Footprint Analysis
  3.6.1 Xerostomia Therapeutics Market: Region Footprint
  3.6.2 Xerostomia Therapeutics Market: Company Product Type Footprint
  3.6.3 Xerostomia Therapeutics Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Xerostomia Therapeutics Production Value Comparison
  4.1.1 United States VS China: Xerostomia Therapeutics Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Xerostomia Therapeutics Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Xerostomia Therapeutics Production Comparison
  4.2.1 United States VS China: Xerostomia Therapeutics Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Xerostomia Therapeutics Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Xerostomia Therapeutics Consumption Comparison
  4.3.1 United States VS China: Xerostomia Therapeutics Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Xerostomia Therapeutics Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Xerostomia Therapeutics Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Xerostomia Therapeutics Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Xerostomia Therapeutics Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Xerostomia Therapeutics Production (2018-2023)
4.5 China Based Xerostomia Therapeutics Manufacturers and Market Share
  4.5.1 China Based Xerostomia Therapeutics Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Xerostomia Therapeutics Production Value (2018-2023)
  4.5.3 China Based Manufacturers Xerostomia Therapeutics Production (2018-2023)
4.6 Rest of World Based Xerostomia Therapeutics Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Xerostomia Therapeutics Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Xerostomia Therapeutics Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Xerostomia Therapeutics Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Xerostomia Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 OTC
  5.2.2 Prescription
5.3 Market Segment by Type
  5.3.1 World Xerostomia Therapeutics Production by Type (2018-2029)
  5.3.2 World Xerostomia Therapeutics Production Value by Type (2018-2029)
  5.3.3 World Xerostomia Therapeutics Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Xerostomia Therapeutics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
  6.2.3 Other
6.3 Market Segment by Application
  6.3.1 World Xerostomia Therapeutics Production by Application (2018-2029)
  6.3.2 World Xerostomia Therapeutics Production Value by Application (2018-2029)
  6.3.3 World Xerostomia Therapeutics Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 GlaxoSmithKline plc
  7.1.1 GlaxoSmithKline plc Details
  7.1.2 GlaxoSmithKline plc Major Business
  7.1.3 GlaxoSmithKline plc Xerostomia Therapeutics Product and Services
  7.1.4 GlaxoSmithKline plc Xerostomia Therapeutics Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 GlaxoSmithKline plc Recent Developments/Updates
  7.1.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.2 Church & Dwight Co., Inc.
  7.2.1 Church & Dwight Co., Inc. Details
  7.2.2 Church & Dwight Co., Inc. Major Business
  7.2.3 Church & Dwight Co., Inc. Xerostomia Therapeutics Product and Services
  7.2.4 Church & Dwight Co., Inc. Xerostomia Therapeutics Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Church & Dwight Co., Inc. Recent Developments/Updates
  7.2.6 Church & Dwight Co., Inc. Competitive Strengths & Weaknesses
7.3 Colgate-Palmolive Company
  7.3.1 Colgate-Palmolive Company Details
  7.3.2 Colgate-Palmolive Company Major Business
  7.3.3 Colgate-Palmolive Company Xerostomia Therapeutics Product and Services
  7.3.4 Colgate-Palmolive Company Xerostomia Therapeutics Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Colgate-Palmolive Company Recent Developments/Updates
  7.3.6 Colgate-Palmolive Company Competitive Strengths & Weaknesses
7.4 Hikma Pharmaceuticals PLC
  7.4.1 Hikma Pharmaceuticals PLC Details
  7.4.2 Hikma Pharmaceuticals PLC Major Business
  7.4.3 Hikma Pharmaceuticals PLC Xerostomia Therapeutics Product and Services
  7.4.4 Hikma Pharmaceuticals PLC Xerostomia Therapeutics Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
  7.4.6 Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
7.5 Pendopharm
  7.5.1 Pendopharm Details
  7.5.2 Pendopharm Major Business
  7.5.3 Pendopharm Xerostomia Therapeutics Product and Services
  7.5.4 Pendopharm Xerostomia Therapeutics Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Pendopharm Recent Developments/Updates
  7.5.6 Pendopharm Competitive Strengths & Weaknesses
7.6 Sun Pharmaceuticals Industries Ltd.
  7.6.1 Sun Pharmaceuticals Industries Ltd. Details
  7.6.2 Sun Pharmaceuticals Industries Ltd. Major Business
  7.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia Therapeutics Product and Services
  7.6.4 Sun Pharmaceuticals Industries Ltd. Xerostomia Therapeutics Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Sun Pharmaceuticals Industries Ltd. Recent Developments/Updates
  7.6.6 Sun Pharmaceuticals Industries Ltd. Competitive Strengths & Weaknesses
7.7 Lupin Pharmaceuticals, Inc.
  7.7.1 Lupin Pharmaceuticals, Inc. Details
  7.7.2 Lupin Pharmaceuticals, Inc. Major Business
  7.7.3 Lupin Pharmaceuticals, Inc. Xerostomia Therapeutics Product and Services
  7.7.4 Lupin Pharmaceuticals, Inc. Xerostomia Therapeutics Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 Lupin Pharmaceuticals, Inc. Recent Developments/Updates
  7.7.6 Lupin Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.8 Pfizer, Inc.
  7.8.1 Pfizer, Inc. Details
  7.8.2 Pfizer, Inc. Major Business
  7.8.3 Pfizer, Inc. Xerostomia Therapeutics Product and Services
  7.8.4 Pfizer, Inc. Xerostomia Therapeutics Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 Pfizer, Inc. Recent Developments/Updates
  7.8.6 Pfizer, Inc. Competitive Strengths & Weaknesses
7.9 Parnell Pharmaceuticals, Inc.
  7.9.1 Parnell Pharmaceuticals, Inc. Details
  7.9.2 Parnell Pharmaceuticals, Inc. Major Business
  7.9.3 Parnell Pharmaceuticals, Inc. Xerostomia Therapeutics Product and Services
  7.9.4 Parnell Pharmaceuticals, Inc. Xerostomia Therapeutics Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Parnell Pharmaceuticals, Inc. Recent Developments/Updates
  7.9.6 Parnell Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.10 Acacia Pharma
  7.10.1 Acacia Pharma Details
  7.10.2 Acacia Pharma Major Business
  7.10.3 Acacia Pharma Xerostomia Therapeutics Product and Services
  7.10.4 Acacia Pharma Xerostomia Therapeutics Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 Acacia Pharma Recent Developments/Updates
  7.10.6 Acacia Pharma Competitive Strengths & Weaknesses
7.11 OraCoat
  7.11.1 OraCoat Details
  7.11.2 OraCoat Major Business
  7.11.3 OraCoat Xerostomia Therapeutics Product and Services
  7.11.4 OraCoat Xerostomia Therapeutics Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 OraCoat Recent Developments/Updates
  7.11.6 OraCoat Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Xerostomia Therapeutics Industry Chain
8.2 Xerostomia Therapeutics Upstream Analysis
  8.2.1 Xerostomia Therapeutics Core Raw Materials
  8.2.2 Main Manufacturers of Xerostomia Therapeutics Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Xerostomia Therapeutics Production Mode
8.6 Xerostomia Therapeutics Procurement Model
8.7 Xerostomia Therapeutics Industry Sales Model and Sales Channels
  8.7.1 Xerostomia Therapeutics Sales Model
  8.7.2 Xerostomia Therapeutics Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION


10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Xerostomia Therapeutics Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Xerostomia Therapeutics Production Value by Region (2018-2023) & (USD Million)
Table 3. World Xerostomia Therapeutics Production Value by Region (2024-2029) & (USD Million)
Table 4. World Xerostomia Therapeutics Production Value Market Share by Region (2018-2023)
Table 5. World Xerostomia Therapeutics Production Value Market Share by Region (2024-2029)
Table 6. World Xerostomia Therapeutics Production by Region (2018-2023) & (K Units)
Table 7. World Xerostomia Therapeutics Production by Region (2024-2029) & (K Units)
Table 8. World Xerostomia Therapeutics Production Market Share by Region (2018-2023)
Table 9. World Xerostomia Therapeutics Production Market Share by Region (2024-2029)
Table 10. World Xerostomia Therapeutics Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Xerostomia Therapeutics Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Xerostomia Therapeutics Major Market Trends
Table 13. World Xerostomia Therapeutics Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Xerostomia Therapeutics Consumption by Region (2018-2023) & (K Units)
Table 15. World Xerostomia Therapeutics Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Xerostomia Therapeutics Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Xerostomia Therapeutics Producers in 2022
Table 18. World Xerostomia Therapeutics Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Xerostomia Therapeutics Producers in 2022
Table 20. World Xerostomia Therapeutics Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Xerostomia Therapeutics Company Evaluation Quadrant
Table 22. World Xerostomia Therapeutics Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Xerostomia Therapeutics Production Site of Key Manufacturer
Table 24. Xerostomia Therapeutics Market: Company Product Type Footprint
Table 25. Xerostomia Therapeutics Market: Company Product Application Footprint
Table 26. Xerostomia Therapeutics Competitive Factors
Table 27. Xerostomia Therapeutics New Entrant and Capacity Expansion Plans
Table 28. Xerostomia Therapeutics Mergers & Acquisitions Activity
Table 29. United States VS China Xerostomia Therapeutics Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Xerostomia Therapeutics Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Xerostomia Therapeutics Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Xerostomia Therapeutics Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Xerostomia Therapeutics Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Xerostomia Therapeutics Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Xerostomia Therapeutics Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Xerostomia Therapeutics Production Market Share (2018-2023)
Table 37. China Based Xerostomia Therapeutics Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Xerostomia Therapeutics Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Xerostomia Therapeutics Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Xerostomia Therapeutics Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Xerostomia Therapeutics Production Market Share (2018-2023)
Table 42. Rest of World Based Xerostomia Therapeutics Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Xerostomia Therapeutics Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Xerostomia Therapeutics Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Xerostomia Therapeutics Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Xerostomia Therapeutics Production Market Share (2018-2023)
Table 47. World Xerostomia Therapeutics Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Xerostomia Therapeutics Production by Type (2018-2023) & (K Units)
Table 49. World Xerostomia Therapeutics Production by Type (2024-2029) & (K Units)
Table 50. World Xerostomia Therapeutics Production Value by Type (2018-2023) & (USD Million)
Table 51. World Xerostomia Therapeutics Production Value by Type (2024-2029) & (USD Million)
Table 52. World Xerostomia Therapeutics Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Xerostomia Therapeutics Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Xerostomia Therapeutics Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Xerostomia Therapeutics Production by Application (2018-2023) & (K Units)
Table 56. World Xerostomia Therapeutics Production by Application (2024-2029) & (K Units)
Table 57. World Xerostomia Therapeutics Production Value by Application (2018-2023) & (USD Million)
Table 58. World Xerostomia Therapeutics Production Value by Application (2024-2029) & (USD Million)
Table 59. World Xerostomia Therapeutics Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Xerostomia Therapeutics Average Price by Application (2024-2029) & (US$/Unit)
Table 61. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline plc Major Business
Table 63. GlaxoSmithKline plc Xerostomia Therapeutics Product and Services
Table 64. GlaxoSmithKline plc Xerostomia Therapeutics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. GlaxoSmithKline plc Recent Developments/Updates
Table 66. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 67. Church & Dwight Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Church & Dwight Co., Inc. Major Business
Table 69. Church & Dwight Co., Inc. Xerostomia Therapeutics Product and Services
Table 70. Church & Dwight Co., Inc. Xerostomia Therapeutics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Church & Dwight Co., Inc. Recent Developments/Updates
Table 72. Church & Dwight Co., Inc. Competitive Strengths & Weaknesses
Table 73. Colgate-Palmolive Company Basic Information, Manufacturing Base and Competitors
Table 74. Colgate-Palmolive Company Major Business
Table 75. Colgate-Palmolive Company Xerostomia Therapeutics Product and Services
Table 76. Colgate-Palmolive Company Xerostomia Therapeutics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Colgate-Palmolive Company Recent Developments/Updates
Table 78. Colgate-Palmolive Company Competitive Strengths & Weaknesses
Table 79. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 80. Hikma Pharmaceuticals PLC Major Business
Table 81. Hikma Pharmaceuticals PLC Xerostomia Therapeutics Product and Services
Table 82. Hikma Pharmaceuticals PLC Xerostomia Therapeutics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 84. Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
Table 85. Pendopharm Basic Information, Manufacturing Base and Competitors
Table 86. Pendopharm Major Business
Table 87. Pendopharm Xerostomia Therapeutics Product and Services
Table 88. Pendopharm Xerostomia Therapeutics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Pendopharm Recent Developments/Updates
Table 90. Pendopharm Competitive Strengths & Weaknesses
Table 91. Sun Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 92. Sun Pharmaceuticals Industries Ltd. Major Business
Table 93. Sun Pharmaceuticals Industries Ltd. Xerostomia Therapeutics Product and Services
Table 94. Sun Pharmaceuticals Industries Ltd. Xerostomia Therapeutics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sun Pharmaceuticals Industries Ltd. Recent Developments/Updates
Table 96. Sun Pharmaceuticals Industries Ltd. Competitive Strengths & Weaknesses
Table 97. Lupin Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Lupin Pharmaceuticals, Inc. Major Business
Table 99. Lupin Pharmaceuticals, Inc. Xerostomia Therapeutics Product and Services
Table 100. Lupin Pharmaceuticals, Inc. Xerostomia Therapeutics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Lupin Pharmaceuticals, Inc. Recent Developments/Updates
Table 102. Lupin Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 103. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer, Inc. Major Business
Table 105. Pfizer, Inc. Xerostomia Therapeutics Product and Services
Table 106. Pfizer, Inc. Xerostomia Therapeutics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pfizer, Inc. Recent Developments/Updates
Table 108. Pfizer, Inc. Competitive Strengths & Weaknesses
Table 109. Parnell Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Parnell Pharmaceuticals, Inc. Major Business
Table 111. Parnell Pharmaceuticals, Inc. Xerostomia Therapeutics Product and Services
Table 112. Parnell Pharmaceuticals, Inc. Xerostomia Therapeutics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Parnell Pharmaceuticals, Inc. Recent Developments/Updates
Table 114. Parnell Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 115. Acacia Pharma Basic Information, Manufacturing Base and Competitors
Table 116. Acacia Pharma Major Business
Table 117. Acacia Pharma Xerostomia Therapeutics Product and Services
Table 118. Acacia Pharma Xerostomia Therapeutics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Acacia Pharma Recent Developments/Updates
Table 120. OraCoat Basic Information, Manufacturing Base and Competitors
Table 121. OraCoat Major Business
Table 122. OraCoat Xerostomia Therapeutics Product and Services
Table 123. OraCoat Xerostomia Therapeutics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Xerostomia Therapeutics Upstream (Raw Materials)
Table 125. Xerostomia Therapeutics Typical Customers
Table 126. Xerostomia Therapeutics Typical Distributors
List of Figure
Figure 1. Xerostomia Therapeutics Picture
Figure 2. World Xerostomia Therapeutics Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Xerostomia Therapeutics Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Xerostomia Therapeutics Production (2018-2029) & (K Units)
Figure 5. World Xerostomia Therapeutics Average Price (2018-2029) & (US$/Unit)
Figure 6. World Xerostomia Therapeutics Production Value Market Share by Region (2018-2029)
Figure 7. World Xerostomia Therapeutics Production Market Share by Region (2018-2029)
Figure 8. North America Xerostomia Therapeutics Production (2018-2029) & (K Units)
Figure 9. Europe Xerostomia Therapeutics Production (2018-2029) & (K Units)
Figure 10. China Xerostomia Therapeutics Production (2018-2029) & (K Units)
Figure 11. Japan Xerostomia Therapeutics Production (2018-2029) & (K Units)
Figure 12. Xerostomia Therapeutics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Xerostomia Therapeutics Consumption (2018-2029) & (K Units)
Figure 15. World Xerostomia Therapeutics Consumption Market Share by Region (2018-2029)
Figure 16. United States Xerostomia Therapeutics Consumption (2018-2029) & (K Units)
Figure 17. China Xerostomia Therapeutics Consumption (2018-2029) & (K Units)
Figure 18. Europe Xerostomia Therapeutics Consumption (2018-2029) & (K Units)
Figure 19. Japan Xerostomia Therapeutics Consumption (2018-2029) & (K Units)
Figure 20. South Korea Xerostomia Therapeutics Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Xerostomia Therapeutics Consumption (2018-2029) & (K Units)
Figure 22. India Xerostomia Therapeutics Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Xerostomia Therapeutics by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Xerostomia Therapeutics Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Xerostomia Therapeutics Markets in 2022
Figure 26. United States VS China: Xerostomia Therapeutics Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Xerostomia Therapeutics Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Xerostomia Therapeutics Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Xerostomia Therapeutics Production Market Share 2022
Figure 30. China Based Manufacturers Xerostomia Therapeutics Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Xerostomia Therapeutics Production Market Share 2022
Figure 32. World Xerostomia Therapeutics Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Xerostomia Therapeutics Production Value Market Share by Type in 2022
Figure 34. OTC
Figure 35. Prescription
Figure 36. World Xerostomia Therapeutics Production Market Share by Type (2018-2029)
Figure 37. World Xerostomia Therapeutics Production Value Market Share by Type (2018-2029)
Figure 38. World Xerostomia Therapeutics Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Xerostomia Therapeutics Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Xerostomia Therapeutics Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Other
Figure 44. World Xerostomia Therapeutics Production Market Share by Application (2018-2029)
Figure 45. World Xerostomia Therapeutics Production Value Market Share by Application (2018-2029)
Figure 46. World Xerostomia Therapeutics Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Xerostomia Therapeutics Industry Chain
Figure 48. Xerostomia Therapeutics Procurement Model
Figure 49. Xerostomia Therapeutics Sales Model
Figure 50. Xerostomia Therapeutics Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source